To have a more complete picture of the tumor immune microenvironment, we also evaluated the ratios (CFRs) of effector T-cells (CD3+, CD8+) to suppressor T-cells (FoxP3+), as prognostic variables. This evidence concerns the gene FOXP3 and neoplasm.